Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)

v3.22.0.1
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities    
Loss for the period $ (11,859) $ (24,931)
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization of intangible assets   2
Depreciation of property and equipment 30  
In-process research and development 16,094 16,094
Change in fair value of milestone liability (4) (11)
Interest expense   16
Amortization of deferred loan costs   51
Warrants issued for services 35 228
Stock option expense 1,641 2,530
Changes in operating assets and liabilities    
Prepaid expenses, deposits and other (678) (2,784)
Accounts payable and accrued liabilities 676 (362)
Related party payables (18) (374)
Net cash used in operating activities (10,177) (9,541)
Cash flows from investing activities    
Cash acquired on merger with Adgero   969
Proceeds on sale of equipment   3
Net cash provided by investing activities   972
Cash flows from financing activities    
Net proceeds from the issuance of shares and warrants 13,634 21,638
Warrants exercised for cash 74 1,180
Stock options exercised for cash   21
Proceeds from loan   500
Series A preferred cash dividend (4) (4)
Net cash provided by financing activities 13,704 23,335
Increase in cash and cash equivalents 3,527 14,766
Cash and cash equivalents – beginning of period 10,537 2,392
Cash and cash equivalents – end of period $ 14,064 $ 17,158